Lilly Battles Virus With Another Deal

Eli Lilly & Co. (LLY) has announced yet another collaboration with a biotech company to battle COVID 19.  This time it is with Junshi Biosciences.

The two companies will strive to co-develop therapeutic antibodies for treatment and prevention of COVID 19.

As President Trump deregulates biotechnology and pharmaceuticals in response to the greater and greater realization that the economy will only recover in the short run if the long run medical solution is no longer in the "long run", more and more companies are diverging resources and effort towards the promise of a Capitalism friendly business environment when this crisis is over with.

Paul Wharton

Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind